LOGO
LOGO

Entrada's Duchenne Drug Trial Results Set For October

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

Duchenne muscular dystrophy (DMD), commonly known as Duchenne, is a rare disorder resulting from mutations in the DMD gene, which is responsible for producing the dystrophin protein. These mutations result in insufficient production of dystrophin.

Dystrophin is crucial for preserving the structural integrity and functionality of muscle cells. The absence of functional dystrophin leads to a gradual decline in muscle strength, affecting mobility and leading to heart and respiratory issues, which significantly increase mortality rates.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.

RELATED NEWS